What do systematic reviews say?

305 questions · 307 findings · 147 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 307 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Biofeedback vs relaxation training

SAEs · people with irritable bowel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Biofeedback plus standard therapy vs sham biofeedback plus standard therapy

SAEs · people with irritable bowel syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Serious adverse events (SAEs) · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and a favourable risk according to the International Metastatic…

The review found no eligible studies for this question.

1 finding from 1 review

First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hysterectomy (simple or radical) with chemoradiotherapy vs chemoradiotherapy alone

Severe/serious adverse events · women with locally advanced cervical cancer

The review found no eligible studies for this question.

1 finding from 1 review

Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Laparoscopic gastric bypass vs laparoscopic adjustable gastric banding

SAEs · participants with obesity

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open)

SAEs · participants with obesity

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Laparoscopic gastric bypass vs laparoscopic duodenojejunal bypass with sleeve gastrectomy

SAEs · participants with obesity

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Laparoscopic adjustable gastric banding vs laparoscopic sleeve gastrectomy

SAEs · participants with obesity

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Laparaoscopic gastric imbrication vs laparoscopic sleeve gastrectomy

SAEs · participants with obesity

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Nanofiltered C1 esterase inhibitor vs placebo or active control

Serious adverse events (during · children or adults with Types I or II HAE

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the long‐term prevention of hereditary angioedema attacks 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Linezolid vs vancomycin

Serious adverse events maximum · neonates and children with hospital‐acquired pneumonia

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotics for hospital‐acquired pneumonia in neonates and children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Usual care with ivabradine vs Placebo, no intervention or usual care (with or without placebo)

Rate of serious adverse events · patients with chronic heart failure with preserved ejection fraction

The review found no eligible studies for this question.

1 finding from 1 review

Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Rate of serious adverse events · patients with acute ischaemic or haemorrhagic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic therapy for preventing infections in people with acute stroke 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Colchicine vs no intervention

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Insulin plus glucagon vs no intervention

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Propylthiouracil vs no intervention

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Glucocorticosteroids vs no intervention

Serious adverse events (number) · participants with severe alcoholic hepatitis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pentoxifylline vs no intervention

Serious adverse events (number) · participants with severe alcoholic hepatitis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anabolic steroids vs no intervention

Serious adverse events (number) · alcohol‐related disorders (others)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Glucocorticosteroids vs no intervention

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found